- Lipid Separation Services
- Lipid Identification Services
Lipidomics Services Market size was valued at USD 50 million in 2022 and is poised to grow at a significant CAGR of 8.0% over 2023-2029. Many lipidomics players have been concentrating on developing new products and biomarker discovery. Burgeoning biomarker discovery is expected to create demand for lipidomics services. Key players focused on adopting innovative MS-based technologies, which helped drive a remarkable transformation in clinical research and biomarker discovery. For example, in June 2017, ProSciento, Inc. and OWL Metabolomics inked an exclusive, multi-year collaboration to establish a database of prospective clinical study participants evaluated for the presence of NAFLD and NASH using non-invasive, lipidomics-based diagnostic assay.
In addition, the increase in the prevalence of chronic diseases and outbreaks such as the Zika virus infection in Latin America and Oceania are expected to offer enormous opportunities for lipidomics players over the forecast period. Furthermore, academic and research institutes accounted for the largest revenue share in the global market, which is attributed to raising funds from public and private sectors for R&D activities and low service costs compared with industries for lipid analysis. Technological advancements in mass spectrometry and chromatography have greatly improved the development and applications of metabolic profiling of diverse lipids in complex biological samples. For instance, novel approaches based on HPLC-ESI-MS/MS permit the quantitation of complex lipid mixtures, and novel approaches based on MALDI-MS imaging allow the imaging of lipid profiles in tissue sections. The high structural diversity and complex nature of lipid molecules is a severe challenge in lipidomics research. For instance, eukaryotic cells provide an excellent example of the structural complexity of lipids. The complete identification of all types of lipids in lipid extracts obtained from cell or tissue samples has not yet been accomplished due to the extraordinary structural diversity of phospholipids.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The surge in demand for accurate disease diagnosis due to the rise in prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is expected to fuel the lipidomics services market over the forecast period. Increased focus on novel treatment solutions and a surge in R&D activities are expected to impact the global lipidomics services market positively. For instance, market players are focusing on R & D for targeted drug deliveries by performing mode-of-action studies, target validation, and the effects of delivery systems on lipid metabolism. Moreover, a rise in R&D funding for various government organizations, universities, and companies is expected to drive the revenue growth of the lipidomics services market in future years. The lipidomics services market is experiencing impressive growth, especially in the emerging countries in the Asia-Pacific and Latin America, such as Brazil, China, and India. However, the high costs of R&D to develop newer therapeutic drugs, as well as the longer R&D timelines and stringent regulations, are significant bottlenecks for the global lipidomics services market. The high structural diversity and complex nature of lipid molecules is a severe challenge in lipidomics research. For instance, eukaryotic cells provide an excellent example of the structural complexity of lipids.
The lipidomics services market is projected to expand at a CAGR of 8.0% during the forecast period.
OWL Metabolomics (Spain), Metabolon, Inc. (U.S.), AS Vitas (Norway), Lipinutragen Srl (Italy), The Metabolomics Innovation Centre
North America is the fastest-growing region for lipidomics services market
1.Executive Summary |
2.Global Lipidomics Services Market Introduction |
2.1.Global Lipidomics Services Market - Taxonomy |
2.2.Global Lipidomics Services Market - Definitions |
2.2.1. By Service Type |
2.2.2. By Sample Type |
2.2.3. By End User |
2.2.4. By Region |
3.Global Lipidomics Services Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Lipidomics Services Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Lipidomics Services Market By Service Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Lipid Separation Services |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Lipid Identification Services |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Lipidomics Services Market By Sample Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Blood Sample |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Tissue Sample |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Lipidomics Services Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Healthcare Industry |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Food Processing Industry |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Cosmetic Industry |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Academic & Research Institutes |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Lipidomics Services Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Lipidomics Services Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Service Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Lipid Separation Services |
9.1.2.Lipid Identification Services |
9.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Blood Sample |
9.2.2.Tissue Sample |
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Healthcare Industry |
9.3.2.Food Processing Industry |
9.3.3.Cosmetic Industry |
9.3.4.Academic & Research Institutes |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Lipidomics Services Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Service Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Lipid Separation Services |
10.1.2.Lipid Identification Services |
10.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Blood Sample |
10.2.2.Tissue Sample |
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Healthcare Industry |
10.3.2.Food Processing Industry |
10.3.3.Cosmetic Industry |
10.3.4.Academic & Research Institutes |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Lipidomics Services Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Service Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Lipid Separation Services |
11.1.2.Lipid Identification Services |
11.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Blood Sample |
11.2.2.Tissue Sample |
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Healthcare Industry |
11.3.2.Food Processing Industry |
11.3.3.Cosmetic Industry |
11.3.4.Academic & Research Institutes |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Lipidomics Services Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Service Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Lipid Separation Services |
12.1.2.Lipid Identification Services |
12.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Blood Sample |
12.2.2.Tissue Sample |
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Healthcare Industry |
12.3.2.Food Processing Industry |
12.3.3.Cosmetic Industry |
12.3.4.Academic & Research Institutes |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Lipidomics Services Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Service Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Lipid Separation Services |
13.1.2.Lipid Identification Services |
13.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Blood Sample |
13.2.2.Tissue Sample |
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Healthcare Industry |
13.3.2.Food Processing Industry |
13.3.3.Cosmetic Industry |
13.3.4.Academic & Research Institutes |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Becton, Dickinson & Company (U.S.) |
14.2.2.Medtronic (U.S.) |
14.2.3.Revolutions Medical Corporation (U.S.) |
14.2.4.Retractable Technologies, Inc. (U.S.) |
14.2.5.Royal Imtech N.V. (Smiths Medical) (Netherlands |
14.2.6.Terumo Corporation (Japan) |
14.2.7.Unilife Corporation (U.S.) |
14.2.8.Sol-Millennium Medical Group (China) |
14.2.9.Ultimed, Inc. (U.S.) |
14.2.10.Axel Bio Corporation (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |